Journal Article

Safety Profile of Smallpox Vaccine: Insights from the Laboratory Worker Smallpox Vaccination Program

James Baggs, Robert T. Chen, Inger K. Damon, Lisa Rotz, Christopher Allen, Kathleen E. Fullerton, Christine Casey, Dale Nordenberg and Gina Mootrey

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 40, issue 8, pages 1133-1140
Published in print April 2005 | ISSN: 1058-4838
Published online April 2005 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/428731
Safety Profile of Smallpox Vaccine: Insights from the Laboratory Worker Smallpox Vaccination Program

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Background. The frequency of mild-to-moderate adverse events following smallpox vaccination was not well documented or reported during the pre-eradication era. This report describes the frequency of such symptoms among 936 adult smallpox vaccinees with and without a history of prior smallpox vaccination.

Methods. Diary cards were distributed to 1006 laboratory workers and members of the Centers for Disease Control and Prevention (CDC) smallpox response team who received smallpox vaccination under an investigational new drug protocol during 2001–2002. Vaccinees were requested to complete the diary card daily and return it to the CDC 28 days after vaccination. The proportion of vaccinees reporting symptoms was determined and compared among subgroups.

Results. Ninety-three percent of the diary cards were returned. The most common symptom reported was “itching at vaccination site.” Primary vaccines reported statistically higher proportions of the following 11 symptoms: joint pain (25% vs. 11%; P = .0011), muscle pain (46% vs. 19%; P < .0001), fatigue (43% vs. 29%; P = .0161), swelling at vaccination site (58% vs. 33%; P < .0001), itching on the body (31% vs. 17%; P = .0048), abdominal pain (11% vs. 2%; P = .0012), swollen or tender lymph nodes (71% vs. 33%; P < .0001), pain at injection site (48% vs. 30%; P = .0018), headache (40% vs. 25%; P = .0088), backache (17% vs. 7%; P = .0090), and fever (temperature, ⩾100°F [37.7°C]; 20% vs. 9%; P = .0047).

Conclusions. This analysis suggests that previously unvaccinated persons aged <30 years experienced more symptoms than did previously vaccinated persons. The findings of increased proportions with joint pain, abdominal pain, backache, and difficulty breathing were unexpected. As with recently described cardiac adverse events, these symptoms are suggestive of systemic involvement and warrant further study.

Journal Article.  3861 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.